跳至主要内容
临床试验/EUCTR2017-001709-33-FR
EUCTR2017-001709-33-FR进行中(未招募)1 期

Randomized, Double-blind, Placebo-controlled Trial on the Efficacy of the Botulinum Toxin for the Treatment of Lateral Epicondylitis - EPITOX

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)0 个研究点目标入组 150 人开始时间: 2017年9月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1) Males or females aged from 18 to 60 years;
  • 2) Whether or not having a professional activity;
  • 3) Whether or not having a motor disability;
  • 4) Unilateral lateral epicondylitis, persistent for more than 3 months, or recurrent and not having responded to at least one reference treatment: local injection of corticosteroids, physical therapy, rest, or NSAIDs;
  • 5) Signing of an informed consent form;
  • 6) Affiliation to a health insurance organism.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 150
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) Central nervous system disorder, which is responsible for spasticity in the limb suffering from epicondylitis;
  • 2) History of severe psychiatric disorder;
  • 3) History of myasthenia gravis;
  • 4) Pregnant or nursing women;
  • 5) Inability to understand or to answer questions;
  • 6) Contra-indication to botulinum toxin or corticosteroids;
  • 7) Injection of botulinum toxin within 3 months prior to inclusion;
  • 8) Taking any anticoagulant drugs;
  • 9) Predictable difficulties of follow-up;
  • 10) Patient under guardianship or curatorship.

研究者

相似试验

尚未招募
不适用
Project goal is eliminate HIV within all systems of the body and to prevent its transmission.HIV/AIDSupper respiratory tract infectionsTuberculosisMalaria
PACTR201401000720267Health Gateway (PTY) Ltd200
进行中(未招募)
不适用
Ferric Carboxymaltose Versus Placebo in Patients with Congestive Heart Failure
EUCTR2012-001134-33-DEniversitätsklinikum Ulm
已完成
不适用
Effectivenessof L-Arginine supplementation for treatment of patients with pulmonary tuberculosisTuberculosis.Tuberculosis of lung, confirmed by sputum microscopy with or without culture
IRCT201211179855N2Arak University of Medical Sciences60
招募中
4 期
Randomized, Double-Blind, Placebo-Controlled Trial of 6 Months versus 12 Months Clopidogrel Therapy After Implantation Of A Drug-Eluting Stent Intracoronary Stenting and Antithrombotic Regimen:Safety And Efficacy of Six-Months Dual Antiplatelet Therapy After Drug-Eluting StentingI20I21I22I23I24I25Angina pectorisSubsequent myocardial infarctionCertain current complications following acute myocardial infarctionOther acute ischaemic heart diseasesChronic ischaemic heart diseaseAcute myocardial infarction
DRKS00000132Klinik für Herz-und KreislauferkrankungenDeutsches Herzzentrum München6,000
Enrolling By Invitation
4 期
Adjunctive vitamin d2 supplement in patient with allergen-specific immunotherapy randomized, double-blind, placebo-controlled trialPatients with allergic rhinitis and asthma begin treatment with allergen-specific immunotherapy.Calciferol, Vitamin D2 , allergic rhinitis, asthma, allergen-specific immunotherapy, TNSS score, ACT score, PEFR, Absolute eosinophil
TCTR20190813001Phramongkutklao Medicine Foundation30